What is eHealth, Inc.'s earnings per share (EPS)?

eHealth, Inc. (EHTH) reported diluted earnings per share of -$0.34 for fiscal year 2025. This represents a 71.4% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

eHealth, Inc. (EHTH) Financials

EHTH

Trailing 12 months to June 30, 2026

Revenue $501.7M -8.4% YoY

Net Income $27.1M -31.5% YoY

EPS (Diluted) -$0.78 -290.0% YoY

Free Cash Flow -$31.5M -28.1% YoY

Market Cap $21.5M as of Oct 3, 2026

Price / Sales 0.0x on $501.7M revenue, trailing 12 months to June 30, 2026

Price / Earnings 0.8x on $27.1M net income, trailing 12 months to June 30, 2026

Price / Book 0.0x on $540.8M equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 3, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 5, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 5, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the EHTH SEC filings page.

eHealth, Inc. (EHTH) reported $501.7M in revenue over the twelve months to Jun 30, 2026, down 8.4% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI EHTH FY2025 2026-10-03

Profitability has returned through margin expansion, but cash remains negative and the balance sheet is carrying more debt.

Positive net income in both FY2024 and FY2025 coincided with negative operating cash flow, revealing a cash-conversion gap rather than merely a one-year earnings mismatch. By FY2025, net income was $40M against operating cash flow of -$25.3M; with capital spending of only $2.3M, free cash flow of -$27.6M points to operating or working-capital cash effects, not heavy reinvestment.

Revenue rose from $452.9M in FY2023 to $554M in FY2025. Operating margin moved from -6.4% to 12.0% over the same span, meaning earnings improved much faster than sales through margin expansion, not volume alone.

Debt-to-equity rose from 0.1x in FY2023 to 0.2x in FY2025, showing the recovery came with greater leverage. The current ratio fell from 4.9x to 3.4x, so short-term liquidity narrowed even while remaining above one.

Financial Health Signals

Financial health score not available

eHealth, Inc. does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Weak

3/9

eHealth, Inc. passes 3 of 9 financial strength tests. 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 efficiency signals pass.

Earnings Quality No Cash Backing

$0.63used

For every $1 of reported earnings, eHealth, Inc. used $0.63 of operating cash (-$25.3M OCF vs $40.0M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely.

Interest Coverage Safe

6.18x

eHealth, Inc. earns $6.18 in operating income for every $1 of interest expense ($66.5M vs $10.8M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$33.6M

YoY-44.8%

QoQ-61.9%

5Y CAGR-19.0%

10Y CAGR-0.7%

eHealth, Inc. generated $33.6M in revenue in Q2 2026. This represents a decrease of 44.8% from the same quarter a year earlier. Against the prior quarter it is down 61.9%.

EBITDA

-$27.0M

YoY-19.4%

QoQ-1029.3%

eHealth, Inc.'s EBITDA was -$27.0M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 19.4% from the same quarter a year earlier. Against the prior quarter it is down 1029.3%.

Net Income

-$23.6M

YoY-35.6%

QoQ-400.5%

eHealth, Inc. reported -$23.6M in net income in Q2 2026. This represents a decrease of 35.6% from the same quarter a year earlier. Against the prior quarter it is down 400.5%.

EPS (Diluted)

-$1.18

YoY-20.4%

eHealth, Inc. earned -$1.18 per diluted share (EPS) in Q2 2026. This represents a decrease of 20.4% from the same quarter a year earlier.

Cash & Balance Sheet

Free Cash Flow

-$5.4M

YoY+87.3%

QoQ-115.3%

eHealth, Inc. recorded an outflow of $5.4M in free cash flow in Q2 2026, representing a cash shortfall after capex. This represents an increase of 87.3% from the same quarter a year earlier. Against the prior quarter it is down 115.3%.

Cash & Debt

$69.7M

YoY+5.7%

QoQ-7.2%

5Y CAGR-21.2%

10Y CAGR+0.4%

eHealth, Inc. held $69.7M in cash against $114.6M in long-term debt as of Q2 2026.

Shares Outstanding

32M

YoY+4.8%

5Y CAGR+4.1%

10Y CAGR+5.7%

eHealth, Inc. had 32M shares outstanding in Q2 2026. This represents an increase of 4.8% from the same quarter a year earlier.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

Gross Margin

15.3%

YoY-15.8pp

QoQ-26.5pp

eHealth, Inc.'s gross margin was 15.3% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is down 15.8 percentage points from the same quarter a year earlier. Against the prior quarter it is down 26.5 percentage points.

Operating Margin

-81.8%

YoY-43.9pp

QoQ-78.5pp

5Y change-55.6pp

10Y change-62.3pp

eHealth, Inc.'s operating margin was -81.8% in Q2 2026, reflecting core business profitability. This is down 43.9 percentage points from the same quarter a year earlier. Against the prior quarter it is down 78.5 percentage points.

Net Margin

-70.3%

YoY-41.7pp

QoQ-64.9pp

5Y change-51.2pp

10Y change-74.5pp

eHealth, Inc.'s net profit margin was -70.3% in Q2 2026, showing the share of revenue converted to profit. This is down 41.7 percentage points from the same quarter a year earlier. Against the prior quarter it is down 64.9 percentage points.

Return on Equity

-4.4%

YoY-1.2pp

QoQ-3.5pp

5Y change-2.1pp

10Y change-5.9pp

eHealth, Inc.'s ROE was -4.4% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is down 1.2 percentage points from the same quarter a year earlier. Against the prior quarter it is down 3.5 percentage points.

Capital Allocation

Capital Expenditures

$488K

YoY-69.2%

QoQ+214.8%

5Y CAGR-9.5%

10Y CAGR-12.7%

eHealth, Inc. invested $488K in capex in Q2 2026, funding long-term assets and infrastructure. This represents a decrease of 69.2% from the same quarter a year earlier. Against the prior quarter it is up 214.8%.

R&D Spending

Not reported for Q2 2026.

Share Buybacks

Not reported for Q2 2026.

EHTH Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

EHTH quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$501.7M	$554.0M+4.1%	$532.4M+17.6%	$452.9M+11.7%	$405.4M-24.7%	$538.2M-7.6%	$582.8M+15.1%	$506.2M+101.4%	$251.4M+31.8%	$190.7M-1.4%	$193.3M-4.9%	$203.3M+13.2%	$179.7M+0.3%	$179.2M+15.2%	$155.5M+2.5%	$151.6M
Cost of Revenue	N/A	$1.3M-25.7%	$1.8M+1.3%	$1.8M+7.5%	$1.6M-17.3%	$2.0M-51.2%	$4.1M+49.1%	$2.7M+123.0%	$1.2M+111.0%	$582K-32.5%	$862K-55.7%	$1.9M-56.7%	$4.5M-17.7%	$5.5M+14.2%	$4.8M-42.6%	$8.3M
Gross Profit	$222.0M	$240.8M+15.5%	$208.5M+31.0%	$159.2M-60.6%	$403.7M-24.7%	$536.2M-7.3%	$578.7M+14.9%	$503.5M+101.3%	$250.2M+31.6%	$190.1M-1.2%	$192.5M-4.4%	$201.4M+15.0%	$175.2M+0.8%	$173.7M+15.3%	$150.7M+5.2%	$143.3M
R&D Expenses	N/A	$13.8M+11.3%	$12.4M-9.5%	$13.7M+13.2%	$12.1M+16.3%	$10.4M+14.3%	$9.1M+12.3%	$8.1M+17.4%	$6.9M-9.2%	$7.6M-14.6%	$8.9M-16.0%	$10.6M-12.4%	$12.1M+19.8%	$10.1M+20.2%	$8.4M+15.1%	$7.3M
SG&A Expenses	$81.8M	$89.6M-0.2%	$89.8M-9.7%	$99.4M+38.4%	$71.8M-5.1%	$75.7M-1.0%	$76.5M+19.2%	$64.2M+40.0%	$45.8M+14.7%	$40.0M+13.5%	$35.2M+16.5%	$30.2M+9.8%	$27.5M-5.8%	$29.2M+11.7%	$26.2M-1.6%	$26.6M
Operating Income	$54.4M	$66.5M+182.1%	$23.6M+181.1%	-$29.1M+71.7%	-$102.7M+18.3%	-$125.6M-335.6%	$53.3M-34.5%	$81.4M+3091.3%	$2.6M+127.0%	-$9.5M-434.8%	$2.8M-72.8%	$10.4M+253.6%	-$6.8M-281.2%	$3.7M-72.2%	$13.4M+1.5%	$13.2M
EBITDA	N/A	$68.4M+167.6%	$25.6M+379.0%	-$9.2M+88.8%	-$81.6M+24.0%	-$107.3M-265.7%	$64.8M-26.6%	$88.2M+1138.8%	$7.1M+227.7%	-$5.6M-188.2%	$6.3M-56.4%	$14.5M+665.4%	-$2.6M-136.4%	$7.0M-55.6%	$15.8M+1.2%	$15.6M
Interest Expense	$13.9M	$10.8M-3.6%	$11.2M+1.7%	$11.0M+43.9%	$7.6M+802.6%	$845K	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	$15.1M	$18.7M+101.9%	$9.3M+488.7%	-$2.4M+86.5%	-$17.7M+13.9%	-$20.5M-340.3%	$8.5M-48.6%	$16.6M+442.0%	$3.1M+109.1%	-$33.7M-1018.6%	$3.7M-52.4%	$7.7M-17.5%	$9.3M+387.5%	$1.9M-69.9%	$6.4M-1.4%	$6.5M
Net Income	$27.1M	$40.0M+296.0%	$10.1M+135.8%	-$28.2M+68.2%	-$88.7M+15.0%	-$104.4M-329.6%	$45.5M-32.0%	$66.9M+27653.9%	$241K-99.1%	$25.4M+8263.8%	$304K-92.3%	$4.0M+124.5%	-$16.2M-1040.5%	$1.7M-75.7%	$7.1M+5.3%	$6.7M
EPS (Basic)	N/A	-$0.34+71.4%	-$1.19+49.8%	-$2.37+45.6%	-$4.36+5.0%	-$4.59-362.3%	$1.75-39.7%	$2.90+28900.0%	$0.01-99.3%	$1.37+6750.0%	$0.02-90.9%	$0.22+125.0%	-$0.88-1077.8%	$0.09-75.0%	$0.36+12.5%	$0.32
EPS (Diluted)	-$0.78	-$0.34+71.4%	-$1.19+49.8%	-$2.37	-$4.36+5.0%	-$4.59-373.2%	$1.68-38.5%	$2.73+27200.0%	$0.01-99.2%	$1.33+6550.0%	$0.02-90.9%	$0.22+125.0%	-$0.88-1077.8%	$0.09-73.5%	$0.34+9.7%	$0.31
Diluted Shares (Avg)	N/A	30M+3.9%	29M+4.7%	28M	27M+2.2%	27M-0.9%	27M+10.1%	25M+20.2%	20M+7.2%	19M+4.0%	18M+1.3%	18M-1.5%	18M-7.5%	20M-4.4%	21M-4.4%	22M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$33.6M-44.8%	$88.0M-22.2%	$326.2M+3.5%	$53.9M-7.8%	$60.8M-7.7%	$113.1M+21.7%	$315.2M+27.3%	$58.4M-9.7%
Gross Profit	$5.1M-72.9%	$36.7M-12.0%	$180.3M+10.0%	-$180K+95.2%	$18.9M0.0%	$41.7M+41.7%	$163.9M	-$3.8M
SG&A Expenses	$15.6M-27.8%	$15.5M-10.4%	$28.7M+4.7%	$21.9M+8.0%	$21.6M-3.7%	$17.3M-11.8%	$27.4M+1.5%	$20.3M-11.5%
Operating Income	-$27.5M-19.2%	-$2.9M-160.0%	$126.3M+12.1%	-$41.5M+3.9%	-$23.0M+17.6%	$4.8M+126.8%	$112.6M+89.7%	-$43.2M-9.7%
EBITDA	-$27.0M-19.4%	-$2.4M-145.3%	$126.8M+24.1%	-$41.1M-4.3%	-$22.6M+4.7%	$5.3M+139.0%	$102.1M+59.2%	-$39.4M-13.6%
Interest Expense	$4.1M+72.7%	$4.0M+52.4%	$3.4M+28.0%	$2.4M-16.6%	$2.3M-17.6%	$2.6M-5.7%	$2.6M-7.4%	$2.9M+1.3%
Income Tax	-$7.1M-6.5%	-$1.4M-176.5%	$34.8M+167.9%	-$11.2M-496.0%	-$6.7M-1217.6%	$1.8M+232.0%	$13.0M+106.9%	-$1.9M+24.8%
Net Income	-$23.6M-35.6%	-$4.7M-341.7%	$87.1M-10.6%	-$31.7M+25.4%	-$17.4M+37.8%	$1.9M+111.5%	$97.5M+86.8%	-$42.5M-14.7%
EPS (Basic)	-$1.18-20.4%	-$0.58-75.8%	$2.44-17.0%	-$1.46+20.2%	-$0.98+26.3%	-$0.33+65.6%	$2.94+94.7%	-$1.83-8.9%
EPS (Diluted)	-$1.18-20.4%	-$0.58-75.8%	$2.44-17.0%	-$1.46+20.2%	-$0.98+26.3%	-$0.33+65.6%	$2.94+94.7%	-$1.83-8.9%
Diluted Shares (Avg)	32M+4.5%	31M+3.8%	N/A	31M+3.9%	30M+4.0%	30M+3.8%	N/A	29M+4.9%

Not reported in any period shown, so not listed: Cost of Revenue, R&D Expenses.

EHTH Balance Sheet

EHTH quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$1.3B+9.3%	$1.2B+3.8%	$1.1B+0.1%	$1.1B-3.2%	$1.1B+10.5%	$1.0B+40.2%	$741.6M+68.8%	$439.3M+22.3%	$359.1M+0.4%	$357.7M+215.6%	$113.3M+6.2%	$106.7M-35.9%	$166.4M-15.2%	$196.3M+10.3%	$177.9M
Current Assets	$334.4M-5.7%	$354.5M-7.3%	$382.4M-4.7%	$401.1M-1.6%	$407.6M+23.1%	$331.0M+59.0%	$208.1M+33.3%	$156.2M+0.3%	$155.7M-9.7%	$172.5M+122.5%	$77.5M+16.6%	$66.5M-46.6%	$124.5M-20.2%	$156.1M+11.7%	$139.7M
Cash & Equivalents	$73.7M+88.1%	$39.2M-66.1%	$115.7M-19.9%	$144.4M+76.3%	$81.9M+87.2%	$43.8M+86.5%	$23.5M+79.3%	$13.1M-67.5%	$40.3M-34.8%	$61.8M-1.5%	$62.7M+22.0%	$51.4M-52.0%	$107.1M-24.0%	$140.8M+13.9%	$123.6M
Short-Term Investments	$3.5M-91.9%	$43.0M+625.9%	$5.9M	$0-100.0%	$41.3M-16.8%	$49.6M	$0	$0	$0	$0	$0	$0	$0	$0	$0
Accounts Receivable	$7.7M-54.3%	$16.8M+320.9%	$4.0M+51.7%	$2.6M-54.2%	$5.8M+219.6%	$1.8M-22.9%	$2.3M-35.2%	$3.6M+144.1%	$1.5M-24.3%	$1.9M-79.8%	$9.6M+17.6%	$8.2M+78.8%	$4.6M+2.6%	$4.5M-44.5%	$8.1M
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	N/A	N/A	$0	$0	$0-100.0%	$40.2M0.0%	$40.2M0.0%	$40.2M+185.4%	$14.1M0.0%	$14.1M0.0%	$14.1M0.0%	$14.1M0.0%	$14.1M0.0%	$14.1M0.0%	$14.1M
Total Liabilities	$670.9M+18.3%	$567.0M+11.8%	$507.3M+9.9%	$461.7M+15.5%	$399.8M+97.5%	$202.5M-5.6%	$214.5M+57.5%	$136.1M+87.9%	$72.5M-31.3%	$105.4M+185.8%	-$122.9M-4.3%	-$117.8M-452.7%	$33.4M+31.4%	$25.4M+14.2%	$22.3M
Current Liabilities	$99.1M+3.2%	$96.0M+22.2%	$78.5M+29.7%	$60.6M-19.7%	$75.5M-10.6%	$84.4M-25.3%	$113.0M+86.4%	$60.6M+138.2%	$25.4M-1.1%	$25.7M-19.4%	$31.9M+19.4%	$26.7M-1.9%	$27.2M+30.9%	$20.8M+13.4%	$18.4M
Non-Current Liabilities	$571.8M+21.4%	$471.0M+9.8%	$428.8M+6.9%	$401.1M+23.7%	$324.3M+174.7%	$118.1M+16.3%	$101.5M+2939.4%	$3.3M+73.9%	$1.9M-54.9%	$4.3M-14.3%	$5.0M-23.1%	$6.4M+4.6%	$6.2M+33.3%	$4.6M+18.0%	$3.9M
Long-Term Debt	$113.0M+65.0%	$68.5M+1.0%	$67.8M+2.5%	$66.1M	$0	N/A	$0-100.0%	$5.0M	$0	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$591.6M+0.5%	$588.4M-2.9%	$606.0M-6.9%	$651.0M-13.2%	$749.5M-10.5%	$837.6M+58.9%	$527.2M+73.9%	$303.1M+5.8%	$286.7M+13.6%	$252.3M+6.8%	$236.2M+5.2%	$224.5M+68.8%	$133.0M-22.2%	$170.9M+9.8%	$155.7M
Retained Earnings	$30.1M+97.5%	$15.2M+109.3%	$7.3M-90.1%	$73.8M-61.8%	$193.2M-38.9%	$316.2M+16.3%	$271.9M+32.6%	$205.0M+0.1%	$204.7M+14.2%	$179.3M+1787.7%	$9.5M-33.4%	$14.3M-53.2%	$30.5M+6.0%	$28.7M+32.7%	$21.7M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$1.2B+7.3%	$1.2B+5.6%	$1.3B+9.3%	$1.0B+4.5%	$1.1B+4.0%	$1.1B+3.8%	$1.2B+3.8%	$1.0B-2.4%
Current Assets	$315.8M-3.8%	$336.6M-8.9%	$334.4M-5.7%	$302.9M-11.1%	$328.2M-7.8%	$369.4M-8.6%	$354.5M-7.3%	$340.9M-14.1%
Cash & Equivalents	$69.7M+5.7%	$75.1M-38.0%	$73.7M+88.1%	$63.1M-1.5%	$65.9M-47.8%	$121.1M-30.8%	$39.2M-66.1%	$64.0M-57.9%
Short-Term Investments	$31.4M-20.1%	$35.7M+3.5%	$3.5M-91.9%	$12.2M-77.3%	$39.3M+58.9%	$34.5M+147.3%	$43.0M+625.9%	$53.8M+534.7%
Accounts Receivable	$1.8M-2.0%	$1.5M-54.6%	$7.7M-54.3%	$1.9M-68.4%	$1.9M+56.9%	$3.4M+140.7%	$16.8M+320.9%	$5.9M+1023.4%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Total Liabilities	$617.2M+17.6%	$625.4M+12.6%	$670.9M+18.3%	$533.2M+6.1%	$524.8M+7.2%	$555.5M+8.3%	$567.0M+11.8%	$502.6M+7.7%
Current Liabilities	$31.7M-71.2%	$44.3M-69.1%	$99.1M+3.2%	$51.2M-4.8%	$110.2M-5.2%	$143.4M-1.8%	$96.0M+22.2%	$53.8M+1.1%
Non-Current Liabilities	$585.5M+41.2%	$581.0M+41.0%	$571.8M+21.4%	$482.0M+7.4%	$414.6M+11.0%	$412.2M+12.4%	$471.0M+9.8%	$448.8M+8.5%
Long-Term Debt	$114.6M	$113.8M	$113.0M+65.0%	$69.4M+0.4%	$0	$0	$68.5M+1.0%	$69.2M+2.7%
Total Equity	$540.8M-2.5%	$575.7M-1.0%	$591.6M+0.5%	$514.2M+3.0%	$554.9M+1.1%	$581.6M-0.2%	$588.4M-2.9%	$499.3M-10.8%
Retained Earnings	-$11.6M+4.4%	$12.0M+127.7%	$30.1M+97.5%	-$43.8M+61.3%	-$12.1M+79.6%	$5.3M+125.8%	$15.2M+109.3%	-$113.4M-229.5%

Not reported in any period shown, so not listed: Inventory, Goodwill.

EHTH Cash Flow Statement

EHTH quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	-$30.5M	-$25.3M-38.0%	-$18.4M-174.4%	-$6.7M+75.1%	-$26.9M+83.5%	-$162.6M-50.8%	-$107.9M-50.9%	-$71.5M-2113.4%	-$3.2M+79.2%	-$15.5M-480.6%	$4.1M-70.2%	$13.7M+669.9%	$1.8M-91.5%	$20.9M-15.8%	$24.9M+10.4%	$22.5M
Depreciation & Amortization	N/A	$1.9M-5.1%	$2.0M-90.0%	$19.9M-5.6%	$21.1M+15.1%	$18.3M+60.1%	$11.4M+68.3%	$6.8M+48.9%	$4.6M+17.9%	$3.9M+10.8%	$3.5M-14.6%	$4.1M-2.4%	$4.2M+27.3%	$3.3M+37.5%	$2.4M0.0%	$2.4M
Stock-Based Compensation	N/A	$15.0M-24.3%	$19.9M-14.4%	$23.2M+14.3%	$20.3M-38.2%	$32.9M+30.5%	$25.2M+11.5%	$22.6M+80.0%	$12.5M+29.4%	$9.7M+33.4%	$7.3M+3.8%	$7.0M+19.1%	$5.9M-24.7%	$7.8M+38.8%	$5.6M-20.8%	$7.1M
Capital Expenditures	$1.0M	$2.3M+7.4%	$2.1M+0.4%	$2.1M+874.8%	$214K-94.5%	$3.9M-50.1%	$7.8M+16.7%	$6.6M+46.5%	$4.5M+142.7%	$1.9M-1.1%	$1.9M+0.5%	$1.9M-47.9%	$3.6M-50.8%	$7.3M+90.1%	$3.9M+60.1%	$2.4M
Free Cash Flow	-$31.5M	-$27.6M-34.9%	-$20.5M-133.1%	-$8.8M+67.6%	-$27.1M+83.7%	-$166.5M-44.0%	-$115.6M-48.0%	-$78.1M-906.3%	-$7.8M+55.4%	-$17.4M-893.5%	$2.2M-81.4%	$11.8M+747.5%	-$1.8M-113.4%	$13.6M-35.3%	$21.0M+4.5%	$20.1M
Investing Cash Flow	-$2.4M	$25.4M+152.5%	-$48.4M-204.7%	-$15.9M-161.5%	$25.9M+304.7%	-$12.6M+82.8%	-$73.3M-332.5%	-$16.9M+34.2%	-$25.8M-407.2%	-$5.1M-36.3%	-$3.7M-24.4%	-$3.0M+63.0%	-$8.1M-10.6%	-$7.3M+27.4%	-$10.1M-53.0%	-$6.6M
Financing Cash Flow	$35.6M	$34.3M+454.4%	-$9.7M-55.4%	-$6.2M-109.7%	$63.8M-70.1%	$213.2M+6.0%	$201.2M+97.0%	$102.1M+5391.5%	$1.9M+313.8%	-$870K+31.4%	-$1.3M-319.9%	$577K+101.2%	-$49.3M-4.1%	-$47.4M-2042.7%	$2.4M+112.0%	-$20.4M
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$0	$0-100.0%	$50.0M-15.3%	$59.0M+525.5%	$9.4M-62.8%	$25.4M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	-$5.0M+88.0%	$35.8M-53.6%	-$35.9M-30.0%	-$25.3M+13.6%	-$41.2M-28.0%	$77.1M+9.0%	-$27.7M+17.1%	-$29.3M-18.6%
Depreciation & Amortization	$490K+5.2%	$490K+4.0%	$497K-1.0%	$447K-88.3%	$466K-89.1%	$471K-89.3%	$502K-89.5%	$3.8M-19.3%
Stock-Based Compensation	$2.3M-39.9%	$2.3M-40.4%	N/A	$3.9M-12.4%	$3.9M-24.1%	$3.8M-31.6%	N/A	$4.5M-31.7%
Capital Expenditures	$488K-69.2%	$155K-49.7%	$143K-77.3%	$214K-78.6%	$1.6M+507.3%	$308K+51.0%	$631K+93.0%	$998K-28.0%
Free Cash Flow	-$5.4M+87.3%	$35.6M-53.6%	-$36.1M-27.6%	-$25.5M+15.7%	-$42.8M-31.9%	$76.8M+8.9%	-$28.3M+16.1%	-$30.3M-16.2%
Investing Cash Flow	$1.9M+119.0%	-$34.4M-727.9%	$6.4M-20.1%	$23.7M+172.5%	-$10.1M+24.8%	$5.5M+153.2%	$8.0M+1240.9%	-$32.7M-234.5%
Financing Cash Flow	-$3.0M+21.2%	-$160K+77.1%	$40.1M+904.9%	-$1.3M-183.6%	-$3.8M-28.9%	-$699K+44.5%	-$5.0M-36.7%	-$450K+49.6%

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

EHTH Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

EHTH quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	43.5%+4.3pp	39.1%+4.0pp	35.1%-64.4pp	99.6%0.0pp	99.6%+0.3pp	99.3%-0.2pp	99.5%0.0pp	99.5%-0.2pp	99.7%+0.1pp	99.6%+0.5pp	99.0%+1.5pp	97.5%+0.5pp	97.0%0.0pp	96.9%+2.4pp	94.5%
Operating Margin	12.0%+7.6pp	4.4%+10.8pp	-6.4%+18.9pp	-25.3%-2.0pp	-23.4%-32.5pp	9.2%-6.9pp	16.1%+15.1pp	1.0%+6.0pp	-5.0%-6.4pp	1.5%-3.6pp	5.1%+8.9pp	-3.8%-5.8pp	2.1%-6.6pp	8.6%-0.1pp	8.7%
Net Margin	7.2%+5.3pp	1.9%+8.1pp	-6.2%+15.7pp	-21.9%-2.5pp	-19.4%-27.2pp	7.8%-5.4pp	13.2%+13.1pp	0.1%-13.2pp	13.3%+13.2pp	0.2%-1.8pp	1.9%+11.0pp	-9.0%-10.0pp	1.0%-3.6pp	4.6%+0.1pp	4.4%
Return on Equity	6.8%+5.0pp	1.7%+6.4pp	-4.7%+9.0pp	-13.6%+0.3pp	-13.9%-19.4pp	5.4%-7.3pp	12.7%+12.6pp	0.1%-8.8pp	8.9%+8.8pp	0.1%-1.6pp	1.7%+8.9pp	-7.2%-8.5pp	1.3%-2.8pp	4.1%-0.2pp	4.3%
Return on Assets	3.2%+2.3pp	0.9%+3.4pp	-2.5%+5.4pp	-8.0%+1.1pp	-9.1%-13.5pp	4.4%-4.7pp	9.0%+9.0pp	0.1%-7.0pp	7.1%+7.0pp	0.1%-3.4pp	3.5%+18.7pp	-15.2%-16.2pp	1.0%-2.6pp	3.6%-0.2pp	3.8%
Current Ratio	3.37-0.3x	3.69-1.2x	4.87-1.8x	6.62+1.2x	5.40+1.5x	3.92+2.1x	1.84-0.7x	2.58-3.5x	6.12-0.6x	6.70+4.3x	2.43-0.1x	2.49-2.1x	4.57-2.9x	7.50-0.1x	7.61
Debt-to-Equity	0.19+0.1x	0.120.0x	0.110.0x	0.10+0.1x	0.00-0.2x	0.24+0.2x	0.000.0x	0.020.0x	0.00-0.4x	0.42	N/A	N/A	0.25+0.1x	0.150.0x	0.14
Asset Turnover	0.440.0x	0.46+0.1x	0.410.0x	0.36-0.1x	0.47-0.1x	0.56-0.1x	0.68+0.1x	0.570.0x	0.530.0x	0.54-1.3x	1.79+0.1x	1.68+0.6x	1.08+0.3x	0.79-0.1x	0.85
FCF Margin	-5.0%-1.1pp	-3.8%-1.9pp	-1.9%+4.7pp	-6.7%+24.3pp	-30.9%-11.1pp	-19.8%-4.4pp	-15.4%-12.4pp	-3.1%+6.0pp	-9.1%-10.3pp	1.1%-4.7pp	5.8%+6.8pp	-1.0%-8.6pp	7.6%-5.9pp	13.5%+0.3pp	13.3%

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Gross Margin	15.3%-15.8pp	41.7%+4.8pp	55.3%+3.3pp	-0.3%+6.1pp	31.1%+2.4pp	36.9%+5.2pp	52.0%	-6.5%
Operating Margin	-81.8%-43.9pp	-3.3%-7.5pp	38.7%+3.0pp	-77.1%-3.1pp	-37.9%+4.5pp	4.2%+23.5pp	35.7%+11.8pp	-74.0%-13.1pp
Net Margin	-70.3%-41.7pp	-5.4%-7.1pp	26.7%-4.2pp	-58.8%+13.9pp	-28.6%+13.9pp	1.7%+20.0pp	30.9%+9.9pp	-72.7%-15.5pp
Return on Equity	-4.4%-1.2pp	-0.8%-1.2pp	14.7%-1.8pp	-6.2%+2.3pp	-3.1%+2.0pp	0.3%+3.3pp	16.6%+8.0pp	-8.5%-1.9pp
Return on Assets	-2.0%-0.4pp	-0.4%-0.6pp	6.9%-1.5pp	-3.0%+1.2pp	-1.6%+1.1pp	0.2%+1.7pp	8.4%+3.8pp	-4.2%-0.6pp
Current Ratio	9.95+7.0x	7.59+5.0x	3.37-0.3x	5.91-0.4x	2.98-0.1x	2.58-0.2x	3.69-1.2x	6.33-1.1x
Debt-to-Equity	0.21+0.2x	0.20+0.2x	0.19+0.1x	0.140.0x	0.000.0x	0.000.0x	0.120.0x	0.140.0x
Asset Turnover	0.030.0x	0.070.0x	0.260.0x	0.050.0x	0.060.0x	0.100.0x	0.27+0.1x	0.060.0x
FCF Margin	-16.2%+54.2pp	40.5%-27.4pp	-11.1%-2.1pp	-47.4%+4.4pp	-70.4%-21.1pp	67.9%-8.0pp	-9.0%+4.6pp	-51.8%-11.6pp

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
eHealth, Inc. EHTH	FY2025	$554.0M	$40.0M	7.2%	$21.5M	—
GoHealth, Inc. GOCO	FY2025	$361.8M	-$257.1M	-71.1%	$5.1M	10/100
AIFU Inc. AIFU	FY2025	$79.6M	-$325.4M	N/A	$60.6M	23/100
TIAN RUIXIANG Holdings Ltd TIRX	FY2024	$5.4M	$617K	11.4%	$2.7M	24/100
XChange TEC.INC XHG	FY2025	$51.3M	-$105.1M	N/A	$95.9M	1/100
TWFG, Inc. TWFG	FY2025	$248.5M	$41.2M	16.6%	$317.0M	10/100

Where eHealth, Inc. Ranks

Frequently Asked Questions

What is eHealth, Inc.'s annual revenue?

eHealth, Inc. (EHTH) reported $554.0M in total revenue for fiscal year 2025. This represents a 4.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is eHealth, Inc.'s revenue growing?

eHealth, Inc. (EHTH) revenue grew by 4.1% year-over-year, from $532.4M to $554.0M in fiscal year 2025.

Is eHealth, Inc. profitable?

Yes, eHealth, Inc. (EHTH) reported a net income of $40.0M in fiscal year 2025, with a net profit margin of 7.2%.

What is eHealth, Inc.'s EBITDA?

eHealth, Inc. (EHTH) had EBITDA of $68.4M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does eHealth, Inc. have?

As of fiscal year 2025, eHealth, Inc. (EHTH) had $73.7M in cash and equivalents against $113.0M in long-term debt.

What is eHealth, Inc.'s gross margin?

eHealth, Inc. (EHTH) had a gross margin of 43.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is eHealth, Inc.'s operating margin?

eHealth, Inc. (EHTH) had an operating margin of 12.0% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is eHealth, Inc.'s net profit margin?

eHealth, Inc. (EHTH) had a net profit margin of 7.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is eHealth, Inc.'s return on equity (ROE)?

eHealth, Inc. (EHTH) has a return on equity of 6.8% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is eHealth, Inc.'s free cash flow?

eHealth, Inc. (EHTH) recorded an outflow of $27.6M in free cash flow during fiscal year 2025. This represents a -34.9% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is eHealth, Inc.'s operating cash flow?

eHealth, Inc. (EHTH) recorded an outflow of $25.3M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

What are eHealth, Inc.'s total assets?

eHealth, Inc. (EHTH) had $1.3B in total assets as of fiscal year 2025, including both current and long-term assets.

What are eHealth, Inc.'s capital expenditures?

eHealth, Inc. (EHTH) invested $2.3M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does eHealth, Inc. spend on research and development?

eHealth, Inc. (EHTH) invested $13.8M in research and development during fiscal year 2025.

How many shares does eHealth, Inc. have outstanding?

eHealth, Inc. (EHTH) had 31M shares outstanding as of fiscal year 2025.

What is eHealth, Inc.'s current ratio?

eHealth, Inc. (EHTH) had a current ratio of 3.37 as of fiscal year 2025, which is generally considered healthy.

What is eHealth, Inc.'s debt-to-equity ratio?

eHealth, Inc. (EHTH) had a debt-to-equity ratio of 0.19 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is eHealth, Inc.'s return on assets (ROA)?

eHealth, Inc. (EHTH) had a return on assets of 3.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is eHealth, Inc.'s P/E ratio?

eHealth, Inc. (EHTH) trades at 0.8x earnings, its market capitalization divided by net income of $27.1M net income, trailing 12 months to June 30, 2026. The market capitalization is $21.5M as of Oct 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is eHealth, Inc.'s price-to-sales ratio?

eHealth, Inc. (EHTH) trades at 0.0x sales, its market capitalization divided by revenue of $501.7M revenue, trailing 12 months to June 30, 2026. The market capitalization is $21.5M as of Oct 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is eHealth, Inc.'s Piotroski F-Score?

eHealth, Inc. (EHTH) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are eHealth, Inc.'s earnings high quality?

For every $1 of reported earnings, eHealth, Inc. (EHTH) used $0.63 of operating cash (-$25.3M OCF vs $40.0M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can eHealth, Inc. cover its interest payments?

eHealth, Inc. (EHTH) has an interest coverage ratio of 6.18x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.